NCT02047162View on ClinicalTrials.gov

Impact of Bismuth Subsalicylate on Antimicrobial Use Among Adult Diarrhea Outpatients--Pakistan

NACompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Diarrhea
Interventions
DRUG

Bismuth subsalicylate

OTHER

Placebo

Chewable tablets identical to intervention tablets, but missing the bismuth subsalicylate

Trial Locations (1)

Unknown

HOPE, Karachi

All Listed Sponsors
collaborator

Procter and Gamble

INDUSTRY

collaborator

Health Oriented Preventive Education

OTHER

lead

Centers for Disease Control and Prevention

FED

NCT02047162 - Impact of Bismuth Subsalicylate on Antimicrobial Use Among Adult Diarrhea Outpatients--Pakistan | Biotech Hunter | Biotech Hunter